THERAZONE ApS: Financial statements 2014
CVR: 27255574
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
THERAZONE ApS (CVR 27255574) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 25,362 and a net result of DKK 509,134 compared with DKK -234,118 the year before. Equity in the 2014 report amounted to DKK 405,740. The solvency ratio was 33.2%.
- Gross Profit
- DKK 25,362
- Profit/Loss
- DKK 509,134
- Equity
- DKK 405,740
- Total Assets
- DKK 1,220,329
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 25 t. | 509 t. | 406 t. | - |
| 2013 | - | -1 t. | -234 t. | -103 t. | - |
| 2012 | - | -12 t. | 193 t. | 131 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
THERAZONE ApS has published its annual report for 2013. Gross profit came to DKK -1,127, and the net result was DKK -234,118.
About THERAZONE ApS
THERAZONE ApS is a Danish company of the type Anpartsselskab based in Dragør, founded in 2003. The company is registered under the industry Investering for egen regning. The management consists of Thomas Magnussen. The company is owned by Thomas Magnussen. According to the 2024 annual report, the company had an average of 2 employees. In 2024, the company reported a gross profit of DKK -255,949 and a net result of DKK 4,003,809 compared with DKK 2,462,806 the year before. Equity in the 2024 report amounted to DKK 44,842,105.